Please login to the form below

Not currently logged in
Email:
Password:

Chemia appoints network manager

Ellie Duncanson-Hunter joins from PMGroup where she was events director

edit-EllieDH-1Chemia - Creston Health's global network of specialist healthcare consultancies - has appointed Ellie Duncanson-Hunter as network manager.

She will manage the day-to-day running of the network and report to the Chemia leadership team, made up of Tim Bird from Cooney/Waters Group, PAN's Eric Hansen and Andrew Thomas from Red Door Communications.

Duncanson-Hunter said of her appointment: “I am thrilled to be taking up this inaugural role and look forward to the challenge of optimising network operations and developing Chemia's global business.”

She joins from PMGroup where she was events director, with responsibility for the Communiqué Awards, PMEAs and Quality in Care programmes after being promoted from the role of awards and marketing manager. Previous to this, she worked at AstraZeneca where she managed events for the primary and specialist care brand teams.

Catherine Warne, CEO of Creston Health, said: “I am delighted to welcome Ellie to the Creston Health family. I have worked with Ellie on Communiqué for the past three years so know she is going to be a great asset to the team.”

Chemia is an integrated network of agencies offering a range of marketing services including public relations, advertising, brand ideation, planning, medical education, digital and social media.

2nd October 2014

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...
Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...